EUVIMEDEUVIMED entdecken
Crossref

Intravenous Dexamethasone for Preventing Postoperative Nausea and/or Vomiting in Total Abdominal Hysterectomy: A randomized double-blinded, placebo-controlled trial

Kanyawee Suhongsa

Thai Journal of Obstetrics and Gynaecology · 01.01.2024

DOI: 10.14456/tjog.2024.22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thai Journal of Obstetrics and Gynaecology, erschienen am 01.01.2024. Verfasst von Kanyawee Suhongsa.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To assess the efficacy of postoperative dexamethasone compared to placebo in reducing the incidence of postoperative nausea and/or vomiting (PONV) in women undergoing benign total abdominal hysterectomy (TAH). Materials and Methods: Participants who were scheduled for TAH with or without adnexal surgery between August 2022 and April 2023 were included. The participants were randomly divided into two groups: the dexamethasone group (n = 43), who received 2 ml (8 mg) of intravenous dexamethasone injection, and the control group (n = 43) received 2 ml of normal saline at 2 hours after surgery.

Results

There was no significant difference in the incidence of PONV within 24 hours between the dexamethasone group and control group (32.6% vs 48.8%, relative risk 0.67(95% confidence interval 0.39 to 1.13), p = 0.09). The need for antiemetic drugs was not statistically different between groups (0% vs 9.3%, p = 0.05), and without serious adverse events in both groups. The dexamethasone group experienced a lesser pain score than the control group at 24 hours (4.7 ± 1.5 vs 5.8 ± 2.2, p = 0.01) after surgery. There was no difference in additional analgesic requirements.

Conclusion

The administration of 8 mg of intravenous dexamethasone postoperatively did not result in a significant reduction in PONV within the first 24 hours following benign TAH.

Schlagwörter

dexamethasonepostoperative nausea and vomitingtotal abdominal hysterectomyantiemetic prophylaxisintravenous corticosteroidsgynecologic surgery

Zitieren

APA

Suhongsa, K. (2024). Intravenous Dexamethasone for Preventing Postoperative Nausea and/or Vomiting in Total Abdominal Hysterectomy: A randomized double-blinded, placebo-controlled trial. Thai Journal of Obstetrics and Gynaecology. https://doi.org/10.14456/tjog.2024.22

Vancouver

Suhongsa K. Intravenous Dexamethasone for Preventing Postoperative Nausea and/or Vomiting in Total Abdominal Hysterectomy: A randomized double-blinded, placebo-controlled trial. Thai Journal of Obstetrics and Gynaecology. 2024. doi:10.14456/tjog.2024.22

BibTeX
@article{Suhongsa2024,
  author = {Suhongsa, Kanyawee},
  title = {Intravenous Dexamethasone for Preventing Postoperative Nausea and/or Vomiting in Total Abdominal Hysterectomy: A randomized double-blinded, placebo-controlled trial},
  journal = {Thai Journal of Obstetrics and Gynaecology},
  year = {2024},
  doi = {10.14456/tjog.2024.22}
}
Kostenlos starten →